News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
846,414 Results
Type
Article (86419)
Company Profile (651)
Press Release (759344)
Multimedia
Podcasts (131)
Webinars (14)
Section
Business (232643)
Career Advice (4127)
Deals (39721)
Drug Delivery (129)
Drug Development (90942)
Employer Resources (198)
FDA (18088)
Job Trends (17339)
News (396349)
Policy (39740)
Tag
Academia (2998)
Academic (1)
Accelerated approval (6)
Adcomms (26)
Allergies (93)
Alliances (56830)
ALS (105)
Alzheimer's disease (1499)
Antibody-drug conjugate (ADC) (158)
Approvals (18057)
Artificial intelligence (306)
Autoimmune disease (28)
Automation (17)
Bankruptcy (403)
Best Places to Work (12616)
BIOSECURE Act (22)
Biosimilars (120)
Biotechnology (448)
Bladder cancer (83)
Brain cancer (30)
Breast cancer (306)
Cancer (2453)
Cardiovascular disease (207)
Career advice (3534)
Career pathing (34)
CAR-T (175)
Cell therapy (490)
Cervical cancer (21)
Clinical research (73436)
Collaboration (927)
Company closure (2)
Compensation (581)
Complete response letters (28)
COVID-19 (2863)
CRISPR (50)
C-suite (271)
Cystic fibrosis (108)
Data (2393)
Decentralized trials (2)
Denatured (46)
Depression (52)
Diabetes (284)
Diagnostics (6916)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (131)
Drug pricing (125)
Drug shortages (29)
Duchenne muscular dystrophy (103)
Earnings (97013)
Editorial (45)
Employer branding (25)
Employer resources (167)
Events (130136)
Executive appointments (773)
FDA (19508)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (817)
Gene editing (125)
Generative AI (27)
Gene therapy (367)
GLP-1 (841)
Government (5166)
Grass and pollen (5)
Guidances (161)
Healthcare (20868)
Huntington's disease (26)
IgA nephropathy (31)
Immunology and inflammation (149)
Indications (30)
Infectious disease (3016)
Inflammatory bowel disease (158)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (102)
Interviews (813)
IPO (17830)
IRA (48)
Job creations (5190)
Job search strategy (2861)
Kidney cancer (11)
Labor market (47)
Layoffs (563)
Leadership (23)
Legal (10102)
Liver cancer (82)
Lung cancer (343)
Lymphoma (161)
Machine learning (9)
Management (65)
Manufacturing (365)
MASH (84)
Medical device (14611)
Medtech (14616)
Mergers & acquisitions (22441)
Metabolic disorders (781)
Multiple sclerosis (88)
NASH (23)
Neurodegenerative disease (116)
Neuropsychiatric disorders (33)
Neuroscience (2111)
NextGen: Class of 2025 (7667)
Non-profit (5079)
Now hiring (41)
Obesity (414)
Opinion (274)
Ovarian cancer (84)
Pain (100)
Pancreatic cancer (91)
Parkinson's disease (162)
Partnered (24)
Patents (258)
Patient recruitment (120)
Peanut (51)
People (65294)
Pharmaceutical (133)
Pharmacy benefit managers (22)
Phase I (22675)
Phase II (31898)
Phase III (24016)
Pipeline (1423)
Policy (176)
Postmarket research (3551)
Preclinical (10236)
Press Release (72)
Prostate cancer (112)
Psychedelics (37)
Radiopharmaceuticals (268)
Rare diseases (427)
Real estate (7391)
Recruiting (75)
Regulatory (26794)
Reports (58)
Research institute (2654)
Resumes & cover letters (649)
Rett syndrome (6)
RNA editing (5)
RSV (44)
Schizophrenia (82)
Series A (143)
Series B (96)
Service/supplier (27)
Sickle cell disease (59)
Special edition (20)
Spinal muscular atrophy (165)
Sponsored (34)
Startups (4295)
State (2)
Stomach cancer (14)
Supply chain (70)
Tariffs (57)
The Weekly (83)
Vaccines (814)
Venture capitalists (45)
Weight loss (289)
Women's health (41)
Worklife (20)
Date
Today (206)
Last 7 days (1016)
Last 30 days (3338)
Last 365 days (34504)
2025 (12536)
2024 (37556)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1270)
Alabama (61)
Alaska (7)
Arizona (267)
Arkansas (14)
Asia (50151)
Australia (8835)
California (6671)
Canada (2099)
China (576)
Colorado (288)
Connecticut (293)
Delaware (166)
Europe (115012)
Florida (980)
Georgia (224)
Hawaii (1)
Idaho (64)
Illinois (618)
India (29)
Indiana (338)
Iowa (12)
Japan (176)
Kansas (113)
Kentucky (26)
Louisiana (14)
Maine (67)
Maryland (987)
Massachusetts (5086)
Michigan (238)
Minnesota (428)
Mississippi (2)
Missouri (85)
Montana (30)
Nebraska (26)
Nevada (70)
New Hampshire (67)
New Jersey (1872)
New Mexico (30)
New York (1871)
North Carolina (1140)
North Dakota (9)
Northern California (2894)
Ohio (218)
Oklahoma (15)
Oregon (46)
Pennsylvania (1467)
Puerto Rico (14)
Rhode Island (35)
South America (1653)
South Carolina (26)
South Dakota (1)
Southern California (2465)
Tennessee (107)
Texas (991)
United States (25336)
Utah (194)
Virginia (165)
Washington D.C. (69)
Washington State (609)
West Virginia (3)
Wisconsin (60)
846,414 Results for "adicet bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adicet Bio Appoints Michael Grissinger to the Board of Directors
April 17, 2025
·
4 min read
Press Releases
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
April 30, 2025
·
1 min read
Press Releases
Adicet Bio Reports First Quarter 2025 Financial Results and Provides Business Updates
May 7, 2025
·
8 min read
Press Releases
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - April 30, 2025
May 1, 2025
·
1 min read
Press Releases
Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference
April 1, 2025
·
1 min read
Press Releases
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
April 28, 2025
·
1 min read
Press Releases
Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2025
April 1, 2025
·
1 min read
Press Releases
Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Systemic Sclerosis (SSc)
February 27, 2025
·
4 min read
Press Releases
Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress
March 6, 2025
·
11 min read
Press Releases
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Securities SMID Cap Biotech Conference
January 29, 2025
·
1 min read
1 of 84,642
Next
